Literature DB >> 21477345

Characterization of a circulating PRRSV strain by means of random PCR cloning and full genome sequencing.

Jan Van Doorsselaere1, Marc Geldhof, Hans J Nauwynck, Peter L Delputte.   

Abstract

PRRS is a pig disease of major economic importance that causes respiratory and reproductive problems in pigs. Over the last years it has become clear that PRRSV heterogeneity is increasing. Consequently, this has a potential impact on diagnosis and strategies to counter this disease. The use of sequence-independent PCR techniques for the detection and characterization of PRRSV could be useful to bypass problems associated with the heterogeneity of this virus. A random PCR cloning approach was tested for the characterization of PRRSV strain 07V063 of unknown genetic background that circulated on a Belgian farm. By using this approach, 7305 bp of sequence data were obtained, distributed randomly across the genome. Using RT-PCR with strain-specific primers, the full length sequence (15014 nt) was obtained. Phylogenetic relationships using ORF5 and ORF1a (NSP2) sequences showed that 07V063 was classified in type 1 subtype 1 and that 07V063 was genetically different from prototype Lelystad Virus (LV). 07V063 showed 87-93% aa identity with LV ORFs coding for structural proteins. Most variation (compared to LV) was noticed in Nsp2 (81% identity) with a deletion of 28 aa. This deletion was different from other known deletions in this ORF. In conclusion, it is shown that this random PCR cloning approach can be used for the characterization of new PRRSV strains of unknown genetic background.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21477345      PMCID: PMC3087698          DOI: 10.1186/1743-422X-8-160

Source DB:  PubMed          Journal:  Virol J        ISSN: 1743-422X            Impact factor:   4.099


Findings

Porcine reproductive and respiratory syndrome (PRRS) is an economically important viral pig disease in swine producing countries worldwide. The virus can cause reproductive disorders and can give rise to respiratory problems in pigs of all ages [1]. Prevention of the disease is based on a combination of management and vaccination. Evidence is accumulating that PRRSV heterogeneity is affecting the vaccination efficiency. It is suggested that vaccines are only efficacious when the vaccine virus and the challenge virus share a sufficiently high homology [2-6]. PRRSV heterogeneity was originally considered mainly to occur between European (genotype 1) and American type (genotype 2) PRRSV, but current understanding shows a more complex situation with considerable genetic variability within genotypes [7-9]. Since such variability may affect the efficacy of vaccination programs and pose an obstacle for PRRSV prevention and control, knowledge on the PRRSV strains circulating on a farm may be essential for choosing an appropriate vaccine [10]. PRRSV diagnosis is mainly based on detection of PRRSV antibodies, Reverse Transcriptase (RT) PCR or virus isolation. Detection of antibodies by ELISA or IPMA is not sufficient to establish the level of PRRSV heterogeneity [11]. RT-PCR allows rapid detection and genotyping of PRRSV, but the high degree of sequence variation observed for PRRSV can influence results obtained by (real-time) RT-PCR and primers and/or probes should be carefully designed based on conserved regions [8,12]. The development of sequence-independent PCR techniques could be useful for the diagnosis and genotyping of unknown PRRSV isolates and for assessment of the PRRSV heterogeneity of field isolates. Several methods have been developed for the identification of viruses without prior sequence knowledge [13]. For instance, whole genome amplification and random PCR are relatively simple. In both these methods, viral particles (from biological samples or cell culture) are treated with DNAse and RNAse to remove contaminating nucleic acids. RNA and/or DNA from the viral particles is extracted and RNA is reverse transcribed to cDNA using a primer with a random 3'end. Subsequently, cDNA or viral DNA is amplified using a shorter primer (without the 3' random end). This results in DNA fragments of varying size (e.g. 0.5 - 2 Kb) and these fragments can be cloned and sequenced. For instance Allander et al. [14] used random PCR on human respiratory tract samples which allowed identification of several unknown viruses. The aim of this study was to test a random PCR cloning technique [14] for the detection and genotyping of a PRRSV strain of unknown genetic background.

Random PCR cloning for the identification of PRRSV 07V063

PRRSV 07V063 was isolated from an aborted foetus from a Belgian farm, by inoculation of porcine alveolar macrophages. On this farm, vaccination with Porcilis™ was in place. PRRS diagnosis was confirmed upon detection of cytopathic effect (CPE), and detection of PRRSV antigens by IPMA staining with the nucleocapsid specific mAb P3/27 [15]. The use of a random PCR approach abrogates the need for a priori sequence information and in combination with small scale shotgun sequencing, this can result in viral sequences. Virus 07V063 was grown on MARC-145 cells and concentrated as described [16] and the viral pellet was treated with DNAseI and RNAse. RNA was extracted using commercial kits and used in reverse transcription and random amplification using the tagged random hexanucleotide 5'-GCCGGAGCTCTGCAGATATCNNNNNN-3' for both first- and second strand cDNA synthesis and subsequent amplification of the cDNA with primer 5'-GCCGGAGCTCTGCAGATATC-3' [14]. Random PCR fragments ranging between 500 and 1200 bp were cloned in pCR-Blunt II-TOPO (Invitrogen). Twenty nine clones were sequenced as described [17]. Twenty three clones (80% of the clones) contained PRRS sequences (Table 1). The six other clones showed no match when performing BlastN http://www.ncbi.nlm.nih.gov. The 07V063 sequences were randomly distributed across the PRRSV genome. Several clones were overlapping and six contigs (with sizes between 622 and 2072 bp) were obtained (Figure 1). Thus, without prior knowledge of the sequence it was possible to obtain 7305 bp sequence data using a random PCR cloning approach, hereby confirming PRRS identity.
Table 1

Overview of the sequences from 07V063 obtained by random PCR cloning.

CloneSize (nt)Position% nt identity
49671774-144481
731981692-188989
1048261808-263389
207982616-341386
1053753069-344388
884293420-384793
333323957-428891
923166198-651293
617136367-707993
1033126768-707994
353646500-686393
122478132-837889
516278931-955786
803589200-955787
8262211225-1184687
1125811225-1148286
8160111928-1252892
7018912336-1252494
4027712364-1264090
7839512991-1338590
5793513195-1412991

The position of the sequences is indicated relative to LV. % nt identity is with LV.

Figure 1

PRRSV genome and position of the contigs. The sequences obtained in the random PCR cloning approach were assembled in six contigs (with sizes between 622 and 2072 bp) dispersed over the genome. The contigs are shown with a line.

Overview of the sequences from 07V063 obtained by random PCR cloning. The position of the sequences is indicated relative to LV. % nt identity is with LV. PRRSV genome and position of the contigs. The sequences obtained in the random PCR cloning approach were assembled in six contigs (with sizes between 622 and 2072 bp) dispersed over the genome. The contigs are shown with a line.

Full length sequence of 07V063 and comparison with prototype LV

To allow a more detailed evaluation of the PRRSV isolate 07V063, the full length genome sequence was obtained using primers that were based on the 07V063 sequences from the random PCR cloning approach (Table 2). Overlapping amplicons (spanning the complete genome) were obtained using RT-PCR. Both strands of these fragments were directly sequenced. For the amplification of the 3'end, oligodT was used in combination with ORF7fw. A 5' end primer (5'endfw) was designed based on the alignment of genotype 1 strains LV (M96262), EuroPRRS (AY366525), SD01-08 (DQ489311), KNU-07 (FJ349261) and HKEU16 (EU076704). This primer was used in combination with primer Lavgsprev to amplify the 5'end. A full length sequence of 15014 nt was obtained. This sequence was deposited in Genbank (Accession GU737264).
Table 2

Oligonucleotide primers used in RT-PCR amplification and nucleotide sequencing of 07V063

PrimerSequencePosition
5'endFWatgatgtgtagggtattccccc1-22
Orf1univFWccctttaaccatgtctggc111-130
Orf1-1fwcatcc gggtg ctgctgg ctt336-355
Orf1-2fwggag ccaccc acgtgtt gac681-701
Lav49fwaatcaatggtattcgtgctg1072-1091
Orf1-3-fwtcaat gcctacaa ctgcccg1631-1650
Orf1-4-fwcttgta taaa ttgct attgg1988-2007
Orf1-5-fwacaa cagg cctc gtaa ggg2472-2490
Lav73fwaaaacttggcgctgcacgtc3102-3121
Orf1-6fwggtcc atta gcca gcgcct3451-3469
Orf1-7fwcttgag cagcg ccaa cattg3686-3705
Lav33fwggtgttggcacggcgagag4129-4147
Orf1-8fwcatgg ctgtt gccca agtgt4538-4557
Orf1-9fwttgt gctt acgcc tggccca4859-4878
Orf1-10fwggcgac tcct ataat cgtat5364-5383
Orf1-11fwccaa gcac ttcg cagg tccg5701-5720
Orf1-12fwggctt ggctg ccgaaa tcgg6096-6115
Orf1-13fwaatgaa gggag tctt gtcta6566-6586
Lav92fwgtgtatccctcggctaccac6891-6911
Orf1-14fwcatta gtcaa cttcaa ggtt7280-7299
Orf1-15fwgga ccc tga gcgg catgaa7765-7783
Lav12fwccaagaactccatggcaggt8172-8191
Orf1-16fwggaaaaacaaattcaaggag8442-8461
Orf1-17fwtccag cccatg ctggt ata8817-8835
Lav51fwgtgtttgtttcactcacact9316-9335
Amp6fwintcatcagaccatgtttgacat9764-9783
Orf1-18fwaaggc caggaa cacca gggt10136-10155
Orf1-19fwcccagta tttgca ccttt gc10633-10652
Orf1-20fwcggccgta cttgc aaccag11132-11150
Orf2afwgts aca cck tat gatta cg11387-11406
LavORF2aseqfwgtgttcgacaacgcccacacgc11577-11598
Orf3fwagcc taca gta caa ca ccac12234-12253
LavORF3seq1fwagcgttgagctcatcttccc12261-12280
Orf4fwcgg ccc ait tcc atccigag12672-12691
Orf5Pesfwtga tca cat tcg gtt gct13320-13337
Orf6fwtacc aa ctt tc ttc tggac13838-13856
Orf7fwtgg cccc tgccc aic acg14328-14345
Orf1-1-revgtcaa cacgt gggtgg ctcc701-681
Lavgsprevcgacttgacattctagtcca900-881
Orf1-2-revagat gcca aacgg acgaa cc1304-1285
Orf1-3-revgcag cctt cgga gcag acgc1796-1777
ORF1-4-revcggtg aaca cgag acacc tg2252-2233
Orf1-5-revgctg atgt tgtc ggatt ctg2615-2596
Orf1-6-revctggg aaca ggagg cgg tgt3202-3182
Orf1-7-revgggttgg atg gagtc gagaa3730-3711
Lav33revccccaacacttgtgacaacg3982-3963
Orf1-8revgt ccgag tccac tacaatc4403-4385
Orf1-9revagag ttgt gccac tgct gaaa4755-4735
Amp3intrev2cagagaaggccggttattcct5023-5003
Amp3intrevgattccaatgagatcacca5609-5591
Orf1-10revgctc ggac taaaa cagc tgg5959-5940
Lav92revcaccaatgatgatgataggg6222-6203
Orf1-11revcttg caca gaca cagtttt6720-6702
Orf1-12revttcaa ggca gttg tca ggct7190-7171
Orf1-13revtca ttaa gacg acacc ggaa7406-7386
Orf1-14revcttg ccat cgga cacaa gg7903-7885
Orf1-15revtga cacc actg agcg ccga8396-8378
Orf1-16revagaca cact ggtg acggggt8696-8676
Lav51revaagaaagctgggtttgtcag8971-8952
Orf1-17revcggaa tctg tttcaa cacag9460-9441
Orf1-18revccagg tggtt gcaa tatcca9944-9925
Orf1-19revaaaactccc gaag ttggtcg10385-10366
Orf1-20revaggc ttgc tgtag tgggcat10762-10743
Lav82revttcaagctggaagtaggc11244-11225
Orf1-21revtgatttt gctcc acag tgac11741-11722
Orf2arevtcatr ccc tatt y tgc acca12558-12539
Orf3revagaa aa gg cacgc ag aaa gca13184-13165
Orf4revcattcagctcgcataicgtcaag13569-13547
Orf5Pesrevggg cgt ata tca tta tag gtg14100-14079
Orf6revacccagc aa ctgg cacag14606-14589
Orf7revtcg ccc taa ttg aa tagg tga14966-14946
Oligonucleotide primers used in RT-PCR amplification and nucleotide sequencing of 07V063 The 5' end and 3'end of 07V063 was 221 nt and 114 nt, respectively. The size of the 5'end of 07V063 is identical with the 5'end of LV with 92.3% identity and 17 nt differences. Several motifs such as the transcription regulatory sequence (UUAACC) and CACCC stretches (involved in binding of host cell transcription factors) are conserved in 07V063 [18]. Table 3 gives an overview of all ORFs in the 07V063 genome and comparison with ORFs from prototype LV. Most variation with LV was noticed in Nsp1 (85% identity/91% similarity) and Nsp2 (81% identity/85% similarity). A major difference is a deletion of 28 aa in a variable region of Nsp2 (at positions 683-710). Similar deletions in this region are known e.g. EuroPRRS has a 17 aa deletion (Figure 2A; [18]). The deletion in NSP2 in 07V63 could be a unique marker for this strain.
Table 3

Comparison of proteins from 07V63 and prototype LV

ORFProteinSize 07V63Size LV% identity% similarity
1aNsp13853858591
Nsp28338618185
Nsp34474479396
Nsp42032039296
Nsp51701709697
Nsp61616100100
Nsp72692699697
Nsp84545100100
1bNsp96456459698
Nsp104424429497
Nsp112242249597
Nsp121521529396
2aGP22492499394
2bE70709597
3GP32652658992
4GP41831838793
5GP52002019194
6M1731739394
7N1281289198
Figure 2

Alignment of Nsp2, ORF4 and ORF5 proteins from 07V063 with LV (ORF4 and ORF5) and a selection of genotype 1 strains (Nsp2). A. Alignment of Nsp2 proteins from genotype 1 strains. Only aa positions 636-755 (LV) are shown. The deletion in 07V063 is located at aa positions 683-710. B. Alignment of GP4 from 07V063 and LV (only the first 120 aa are shown). A neutralizing epitope in LV (57-68) is underlined. C. Alignment of GP5 from 07V063 and LV. A neutralizing epitope in North American strains (37-45) is underlined.

Comparison of proteins from 07V63 and prototype LV Alignment of Nsp2, ORF4 and ORF5 proteins from 07V063 with LV (ORF4 and ORF5) and a selection of genotype 1 strains (Nsp2). A. Alignment of Nsp2 proteins from genotype 1 strains. Only aa positions 636-755 (LV) are shown. The deletion in 07V063 is located at aa positions 683-710. B. Alignment of GP4 from 07V063 and LV (only the first 120 aa are shown). A neutralizing epitope in LV (57-68) is underlined. C. Alignment of GP5 from 07V063 and LV. A neutralizing epitope in North American strains (37-45) is underlined. Strain 07V063 showed 87 - 95% aa identity with LV for the structural ORFs 2 - 7. We compared GP4 and GP5 proteins from 07V063 and LV since it has been shown that these proteins are the main target for neutralizing antibodies. Figure 2B shows an alignment of ORF4 proteins. Notably is the high variation in the region 50-70. It has been shown that a neutralizing epitope is present in LV at positions 57-68 [19] and that this region is under antibody-mediated pressure in vitro and in vivo [20,21]. Pigs infected with 07V063 produce neutralizing antibodies against the 57RVTAAQGRIYTR68 epitope. However, these antibodies do not cross-protect against LV [22]. Similarly, antibodies against the same region in LV, do not cross-protect against 07V063. Interestingly, this lack of cross-neutralization is in agreement with the finding that strain 07V063 was able to replicate and cause disease on a farm where animals were vaccinated with the LV-like Porcilis™ vaccine. GP5 has been described as the main target for virus-neutralizing antibodies in North American PRRSV strains. A neutralizing epitope has been identified at positions 37-45 [23]. Figure 2C shows that 07V063 and LV have an identical sequence from 37-45 with the exception of an extra glycosylation site at position 37 in 07V063. It has been shown that several strains are glycosylated at this position but the significance of this glycosylation is not known. Other amino acid changes occur throughout the sequence and several of these positions have been described as variable [24]. No other differences in glycosylation pattern of the structural proteins between 07V063 and LV was observed.

Phylogenetic relationship of 07V063

Since ORF5 is frequently used as a marker for the study of genetic relationships [8], we constructed phylogenetic trees using ORF5 sequences from a selection of genotype 1 strains (Table 4). In addition genotype 1 strains for which the full length sequence was available in Genbank were included. VR-2332 (genotype 2) was used as out-group.
Table 4

Overview of strains used for phylogenetic analysis

StrainGenotypeGenbank Accession ORF5Genbank Accession ORF1a (nsp2)
VR-23322U87392U87392
Lelystad1 (subtype 1)M96262M96262
EuroPRRS1AY366525AY366525
01-CB11 (subtype 1)DQ864705DQ864705
Amervac1 (subtype 1)GU067771GU067771
HKEU161 (subtype 1)EU076704EU076704
KNU-071 (subtype 1)FJ349261FJ349261
SHE1 (subtype 1)GQ461593GQ461593
SD01-081 (subtype 1)DQ489311DQ489311
BJEU06-11 (subtype 1)GU047344GU047344
NMEU09-11 (subtype 1)GU047345GU047345
07V0631 (subtype 1)GU737264GU737264
PyrsVac1 (subtype 1)DQ324681ND
Porcilis1 (subtype 1)AAW78901ND
Olot/911 (subtype 1)X92942ND
Yuz-341 (subtype 3)DQ324692ND
Bel-421 (subtype 3)DQ324669ND
Obu-11 (subtype 3)DQ324671ND
Soz-61 (subtype 3)DQ324686ND
Dzi-621 (subtype 1)DQ324675ND
Cresa111 (subtype 1)DQ009626ND
IV31401 (subtype 1)DQ355821ND
28639/981 (subtype 1)AY035912ND
361-41 (subtype 1)AY035915ND
Sno-42 (subtype 2)DQ324683ND
Sid2 (subtype 2)DQ324682ND
Aus2 (subtype 2)DQ324667ND
Okt-351DQ324677ND
16/20001DQ345743ND
SD02-111 (subtype 1)AY395078AY383634
SD01-071 (subtype 1)AY395079AY383632
SD03-121 (subtype 1)AY395074AY383635
SD03-151 (subtype 1)AY395076AY383636
It-221 (subtype 1)AY739978ND
It-391 (subtype 1)AY739995ND
It-441 (subtype 1)AY740000ND
It-351 (subtype 1)AY739991ND
It-131 (subtype 1)AY739969ND
Lena1 (subtype 3)EU909691ND

The type of the strains is according to Stadejek et al (2008). ND = no data. VR-2332 is genotype 2. Eleven genotype 1 isolates for which full length sequences were obtained are listed first.

Overview of strains used for phylogenetic analysis The type of the strains is according to Stadejek et al (2008). ND = no data. VR-2332 is genotype 2. Eleven genotype 1 isolates for which full length sequences were obtained are listed first. Figure 3A shows a phylogenetic tree of ORF5 DNA sequences based on the Neighbour Joining (NJ) method. Several clusters are evident and supported by high bootstrap values. It can be concluded that 07V063 clusters within the pan-European subtype 1 [8]. Within subtype 1, a cluster with LV- and Olot/91-like strains can be distinguished. Although both LV and Olot/91 belong to the earliest PRRSV isolates, still LV and Olot/91-like strains such as SD01-08 are circulating. Strain 07V063 is genetically different from LV- and Olot/91- like strains. Apparently 07V063 clusters together with isolates from different geographical locations e.g. isolates from Spain (16/2000), Denmark (361-4), China (BJEU06-1) and South-Korea (IV3140) although this clustering is not supported by high bootstrap values. A similar tree topology was obtained using ORF5 protein sequences (data not shown). The sub-clustering of type 1 is complex and cannot always be explained by geographic isolation of the strains [8]. The sequence of 07V63 adds to the increase of genetic diversity of type 1 strains and is an example of continuous genetic drift within PRRSV [24]. A recent PRRSV study in Spain [25] demonstrated that Spanish isolates from different years show continuous evolution and increase in heterogeneity and that different genotypes and variants within the genotypes co-circulate.
Figure 3

Phylogenetic relationship of 07V063. Phylogenetic trees were derived from multiple sequence alignments using Phylip v3.67. Bootstrapping was performed 500 times using SEQBOOT. Pairwise distances between DNA and/or protein sequences were determined with DNAdist and PROTdist, respectively. Neighbour-Joining (NJ) trees were calculated with NEIGHBOUR and Maximum Likelyhood (ML) trees with DNAML and PROML. Majority rule consensus trees were calculated using CONSENSE. The percentage confidence is indicated on the branches (500 datasets). Trees, constructed using NJ method, based on ORF5 DNA (A) or ORF1a (Nsp2) DNA (B) sequences. Strain 07V063 is underlined. VR-2332 was used as outgroup.

Phylogenetic relationship of 07V063. Phylogenetic trees were derived from multiple sequence alignments using Phylip v3.67. Bootstrapping was performed 500 times using SEQBOOT. Pairwise distances between DNA and/or protein sequences were determined with DNAdist and PROTdist, respectively. Neighbour-Joining (NJ) trees were calculated with NEIGHBOUR and Maximum Likelyhood (ML) trees with DNAML and PROML. Majority rule consensus trees were calculated using CONSENSE. The percentage confidence is indicated on the branches (500 datasets). Trees, constructed using NJ method, based on ORF5 DNA (A) or ORF1a (Nsp2) DNA (B) sequences. Strain 07V063 is underlined. VR-2332 was used as outgroup. Also, phylogenetic trees using Nsp2 were constructed (Figure 3B). Sequences from all known full length genotype 1 strains (Table 4) were included. Essentially, the same topology can be observed as for ORF5. A cluster of LV-like strains is evident and supported by high bootstrap values. As was already observed from the ORF5 phylogenetic tree, Amervac and SHE are very closely related as is the case for strains 01-CB1 and LV. 07V063 clusters apart from LV and is genetically distinct from the LV prototype.

Conclusions

By using a simple random PCR cloning approach we obtained PRRSV sequence data from a recent European PRRSV isolate of unknown genetic background. This approach can be used to obtain partial genome sequences from for instance East-European type strains (for which until present, no full length genomes are available) and to get a better knowledge of the increasing PRRSV variability. We also showed that the isolate sequenced in this study is genetically different from prototype LV.

List of abbreviations

PRRSV: porcine reproductive and respiratory syndrome virus; RT-PCR: reverse transcriptase polymerase chain reaction.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

JVD carried out the molecular characterization and drafting of the manuscript. MG isolated the virus and performed IPMA analysis. HJN participated in coordination and supervision of this work. PLD participated in the design and coordination of the study and drafting of the manuscript. All authors read and approved the manuscript.
  25 in total

1.  Posttranslational processing and identification of a neutralization domain of the GP4 protein encoded by ORF4 of Lelystad virus.

Authors:  J J Meulenberg; A P van Nieuwstadt; A van Essen-Zandbergen; J P Langeveld
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Porcine reproductive and respiratory syndrome virus (PRRSV): monoclonal antibodies detect common epitopes on two viral proteins of European and U.S. isolates.

Authors:  M Wieczorek-Krohmer; F Weiland; K Conzelmann; D Kohl; N Visser; P van Woensel; H J Thiel; E Weiland
Journal:  Vet Microbiol       Date:  1996-08       Impact factor: 3.293

3.  New insights into the genetic diversity of European porcine reproductive and respiratory syndrome virus (PRRSV).

Authors:  S Pesch; C Meyer; V F Ohlinger
Journal:  Vet Microbiol       Date:  2005-04-25       Impact factor: 3.293

4.  Failure to consider the antigenic diversity of porcine reproductive and respiratory syndrome (PRRS) virus isolates may lead to misdiagnosis.

Authors:  K J Yoon; J J Zimmerman; M J McGinley; J Landgraf; M L Frey; H T Hill; K B Platt
Journal:  J Vet Diagn Invest       Date:  1995-07       Impact factor: 1.279

Review 5.  GP4-specific neutralizing antibodies might be a driving force in PRRSV evolution.

Authors:  Sarah Costers; Merijn Vanhee; Wander Van Breedam; Jan Van Doorsselaere; Marc Geldhof; Hans J Nauwynck
Journal:  Virus Res       Date:  2010-09-15       Impact factor: 3.303

6.  Porcine arterivirus infection of alveolar macrophages is mediated by sialic acid on the virus.

Authors:  Peter L Delputte; Hans J Nauwynck
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

7.  Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.

Authors:  G Labarque; K Van Reeth; H Nauwynck; C Drexler; S Van Gucht; M Pensaert
Journal:  Vaccine       Date:  2004-10-22       Impact factor: 3.641

8.  Characterization of emerging European-like porcine reproductive and respiratory syndrome virus isolates in the United States.

Authors:  Susan L Ropp; Carrie E Mahlum Wees; Ying Fang; Eric A Nelson; Kurt D Rossow; Melissa Bien; Bill Arndt; Sarah Preszler; Pamela Steen; Jane Christopher-Hennings; James E Collins; David A Benfield; Kay S Faaberg
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Lelystad virus, the cause of porcine epidemic abortion and respiratory syndrome: a review of mystery swine disease research at Lelystad.

Authors:  G Wensvoort; E P de Kluyver; J M Pol; F Wagenaar; R J Moormann; M M Hulst; R Bloemraad; A den Besten; T Zetstra; C Terpstra
Journal:  Vet Microbiol       Date:  1992-11       Impact factor: 3.293

Review 10.  Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development.

Authors:  X J Meng
Journal:  Vet Microbiol       Date:  2000-06-12       Impact factor: 3.293

View more
  3 in total

1.  Complete genome characterization of a East European Type 1 subtype 3 porcine reproductive and respiratory syndrome virus.

Authors:  J Van Doorsselaere; M S Brar; M Shi; U Karniychuk; F C-C Leung; H J Nauwynck
Journal:  Virus Genes       Date:  2011-09-27       Impact factor: 2.332

2.  Concise and broadly applicable method for determining the genomic sequences of North-American-type porcine reproductive and respiratory syndrome viruses in various clusters.

Authors:  Takeya Morozumi; Hiroshi Iseki; Daisuke Toki; Michihiro Takagi; Hiroshi Tsunemitsu; Hirohide Uenishi
Journal:  J Vet Med Sci       Date:  2014-06-10       Impact factor: 1.267

3.  Phenotypic Characterization of a Virulent PRRSV-1 Isolate in a Reproductive Model With and Without Prior Heterologous Modified Live PRRSV-1 Vaccination.

Authors:  Heinrich Kreutzmann; Julia Stadler; Christian Knecht; Elena L Sassu; Ursula Ruczizka; Yury Zablotski; Eleni Vatzia; Gyula Balka; Marianne Zaruba; Hann-Wei Chen; Christiane Riedel; Till Rümenapf; Andrea Ladinig
Journal:  Front Vet Sci       Date:  2022-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.